Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Stocks shake off global recovery worries

Fri, 09th Jul 2021 12:07

(Alliance News) - European stocks roared back on Friday from coronavirus-driven jitters in the previous session, with a weak UK GDP reading unable to stop the FTSE 100 advancing nearly 50 points by midday.

The FTSE 100 index was up 48.18 points, or 0.7%, at 7,078.84 midday Friday. The mid-cap FTSE 250 index was up 160.38 points, or 0.7%, at 22,813.10. The AIM All-Share index was 0.1% lower at 1,247.37.

The Cboe UK 100 index was up 0.7% at 704.55. The Cboe 250 was up 0.6% at 20,495.72, and the Cboe Small Companies up 0.2% at 15,418.98.

Stocks were rebounding at the end of a difficult week after worries over the global economic rebound in the face of the more infectious Delta coronavirus variant pounded markets on Thursday.

"Concerns over slowing global economic growth, rising Delta cases and the Fed moving towards tightening monetary policy proved too much for the markets to swallow," said Sophie Griffiths, market analyst at Oanda.

"Key technical levels were tested but not meaningfully breached," she said. "As a result, dip buyers are back in today, picking up bargains."

In mainland Europe early Friday afternoon, the CAC 40 in Paris surged 1.7% amid broad-based gains throughout the index while the DAX 30 in Frankfurt gained 0.8%.

Wall Street is also on course for a bright Friday, with the Dow Jones called up 0.4% and the S&P 500 up 0.2% but the Nasdaq Composite pointed down 0.3%

"Big tech could be under the spotlight as finance ministers and central bankers from the 20 largest economies meet in Vienna. Corporate tax reform will be at the top of the agenda, as the group looks to build on the momentum created at the G7 meeting," the Oanda analyst said.

London stocks were managing to shake off fears over economic growth peaking even after a weaker-than-expected UK gross domestic product reading.

UK GDP grew 0.8% in May from April, missing forecasts for a stronger monthly gain of 1.7%, according to FXStreet, and below April's growth of 2.0%, which itself was revised down from 2.3%. The economy remains 3.1% below its pre-virus levels, the ONS said.

ING remained upbeat despite the disappointing May figure.

"We'd still expect positive third-quarter growth of around 1.5%, especially given we're not currently looking at new restrictions – and indeed the government is planning a further relaxation on 19 July. And we'd still say the outlook beyond the summer looks reasonably good," said ING.

Sterling was trading at USD1.3801 at midday, up from USD1.3763 at the London equities close on Thursday.

The euro traded at USD1.1857 on Friday, rising from USD1.1842 late Thursday in London. Against the yen, the dollar rose to JPY109.91 versus JPY109.79.

Gold was quoted at USD1,804.29 an ounce midday Friday, higher than USD1,796.50 on Thursday. Brent oil was trading at USD74.70 a barrel, up from USD73.70 late Thursday.

Helping to support London's FTSE 100 index were ratings upgrades for Bunzl and Burberry. Bunzl was lifted to Buy from Hold at Berenberg, while Goldman Sachs upgraded trenchcoat maker Burberry to Buy from Neutral. Bunzl was up 2.8% at midday, while Burberry was up 3.0%.

Land Securities also was amongst the top performers, up 2.6%, after reporting "good progress" on rent collection.

As of Wednesday, the FTSE 100-listed property owner said that it has collected 81% of the GBP103 million net rent due by June 24. It also said it will pay a 7.0 pence per share dividend in October in its first quarterly payout for financial 2022.

At the bottom of London's blue-chip index was lockdown winner Just Eat Takeaway.com, falling 2.1% as jitters over the global economic recovery calmed.

Vectura shares surged 13% to 153.40 pence, topping the mid-cap FTSE 250 index, after agreeing to be taken over Marlboro cigarette maker Philip Morris International.

Philip Morris will pay 150p per share in cash for Vectura, a Wiltshire, England-based inhaled drug delivery devices maker. Including a 19p interim dividend, the deal values Vectura at GBP1.04 billion.

Following the PMI offer, Vectura's directors withdrew their recommendation for a GBP958 million takeover by funds managed by private equity firm Carlyle Group. PMI's offer is a 10% premium to Carlyle's 136p per share bid.

"PMI is expanding into products beyond tobacco and nicotine, as part of a natural evolution into a broader healthcare and wellness company," the New York-based company said.

Philip Morris shares were trading 0.6% higher pre-market in New York. The company is worth USD153.3 billion.

Elsewhere in London, MJ Gleeson rose 3.5% as it guided that annual results will top market expectations and match pre-virus levels.

The housebuilder said pretax profit for the financial year ended June 30 will be in line with two years earlier. MJ Gleeson posted pretax profit of GBP41.2 million in financial 2019, on revenue of GBP249.9 million. In financial 2020, revenue dropped 41% to GBP147.2 million, with pretax profit tumbling 86% to GBP5.6 million.

CEO James Thomson said: "I am pleased to announce that pretax profit is expected to be in line with that achieved in 2019, our last financial year before the impact of the pandemic."

To come in Friday's economic calendar are European Central Bank meeting minutes at 1230 BST and Canadian unemployment at 1330 BST.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
19 Apr 2018 12:53

hVIVO CEO Steps Down In Favour Of Executive Chair As Loss Narrows

LONDON (Alliance News) - Clinical development and drug discovery business hVIVO PLC said Thursday its loss narrowed in 2017 as Chief Executive Kym Denny stepped aside for Executive Chairman Trevor

Read more
3 Apr 2018 08:41

EUROPE RESEARCH ROUNDUP-Aevis Victoria, Martela Oyj, Mediaset

April 3 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Aevis Victoria, Martela Oyj and Mediaset, on Tuesday. HIGHLIGHTS * Aevis SA

Read more
23 Mar 2018 18:23

DIRECTOR DEALINGS: Vectura Non-Executive Juliet Thompson Buys Shares

LONDON (Alliance News) - Vectura Group PLC said Friday Non-Executive Director Juliet Thompson bought shares worth GBP36,284 in the pharmaceutical company after

Read more
22 Mar 2018 16:16

DIRECTOR DEALINGS: Vectura Chairman, Non-Exec Director Buy Shares

LONDON (Alliance News) - Vectura Group PLC said on Thursday that two directors bought shares in the company on Wednesday.Chairman Bruno Angelici purchased 75,000 shares

Read more
21 Mar 2018 08:52

Vectura Delivers "Good" 2017 Results Despite Advair Disappointment

LONDON (Alliance News) - Pharmaceutical firm Vectura Group PLC said Wednesday it delivered a "good" set of 2017 results with underlying profit and revenue growth to

Read more
21 Mar 2018 08:31

UPDATE 1-UK's Vectura posts wider 2017 loss, revenue rise

March 21 (Reuters) - British drugmaker Vectura reported a worse-than-expected pretax loss for the full year on Wednesday, dragged by lower royalties and higher costs related to the SkyePharma for

Read more
21 Mar 2018 07:47

UPDATE 1-UK Stocks-Factors to watch on March 21

March 21 (Reuters) - Britain's FTSE 100 index is seen opening up 13 points on Wednesday, according to financial bookmakers, with futures 0.26 pct higher ahead of the cash

Read more
21 Mar 2018 07:40

Drugmaker Vectura's 2017 revenue rises 17.2 pct

March 21 (Reuters) - British drugmaker Vectura reported a 17.2 percent rise in 2017 revenue on Wednesday, aided by higher demand for its asthma products Flutiform and Ultibro. The company,

Read more
20 Mar 2018 13:21

Legal & General Increases Vectura Stake To 3.7% From Below 3% (ALLISS)

LONDON (Alliance News) - Vectura Group PLC said Tuesday FTSE 100-listed insurer and asset manager Legal & General Group PLC increased its stake in the pharmaceutical firm

Read more
14 Mar 2018 16:20

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 15 March Old MutualFull Year ResultsPhoenix GroupFull Year GroupFull 16

Read more
12 Mar 2018 10:43

WINNERS & LOSERS SUMMARY: Vectura And Hikma Hurt By US FDA Ruling

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------easyJet, up 2.3% at on

Read more
12 Mar 2018 09:43

FTSE 100 lags Europe on miners and energy, Just Eat goes cold

(For a live blog on European stocks, type LIVE/ in an Eikon news window) * FTSE 100 up 0.1 pct * Just Eat hit by DB downgrade * Vectura, Hikma hit by delay to Advair GKN up 12

Read more
16 Feb 2017 07:49

Vectura Hits GBP9 Million Royalty Cap Under Skyepharma Legacy Deal

Read more
16 Feb 2017 07:06

Vectura's GSK royalties agreements firing on all cylinders

(ShareCast News) - Vectura Group hit its royalty cap on sales of GlaxoSmithKline´s Ellipta range of products in 2016, one year ahead of forecasts. The cap was equivalent to £9.0m. The inhaled airways disease-focused business was also set to record £5.4m of 2016 revenues under a separate single digi

Read more
8 Feb 2017 13:49

UPDATE 1-Weak pound buoys GSK but drugmaker warns on 2017 generic threat

* 2017 core EPS seen flat-lower if mid-year generic Advair * Current exchange rates would lift 2017 sterling EPS 9 pct * Q4 2016 core EPS 26.1 pence vs consensus forecast 25.0p (Adds CEO comments, shares, background on new CEO) By Ben Hirschler LONDON, Feb 8 (Reuters) -

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.